GlassScriptPhysician profile
Angela D Hunter
NPI 1932437035
$1,112.29
in general payments reported to CMS, 2019-2025
12 companies · $460 in 2025
The $460 reported for 2025 was more than what 95% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $30.59 · 2023: $362 · 2024: $259 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $917 · Education: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $916.72 |
| Education | $164.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $478.12 | 2023-2025 | Niktimvo, Jakafi, Jakafi |
| Teleflex LLC | $256.29 | 2022-2025 | Arrow |
| Astrazeneca Pharmaceuticals LP | $121.18 | 2023 | |
| Jazz Pharmaceuticals INC. | $57.68 | 2024 | |
| Sanofi-Aventis U.S. LLC | $55.12 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $26.30 | 2025 | Opdualag |
| Genentech USA, INC. | $24.56 | 2025 | Polivy |
| Kite Pharma, INC. | $22.69 | 2025 | Yescarta |
| Alexion Pharmaceuticals, INC. | $21.83 | 2023 | Ultomiris |
| Glaxosmithkline, LLC. | $18.88 | 2025 | Ojjaara, Jemperli |
| Sanofi Pasteur INC. | $15.64 | 2023 | |
| Servier Pharmaceuticals LLC | $14.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.